Advertisement

Transgenic Models of Chronic Arthritis and of Systemic Tumour Necrosis Factor-Mediated Disease in Mice Expressing Human Tumour Necrosis Factor

  • George A. Kollias
Conference paper
Part of the Schering Foundation Workshop book series (SCHERING FOUND, volume 6)

Abstract

Tumour necrosis factor (TNF-α/cachectin, TNF) was discovered originally as a factor displaying cytotoxic/cytostatic effects on transformed cells in vitro and necrotizing activity on certain transplantable tumours in vivo (Carswell et al. 1975). In later studies, TNF was shown to be the primary mediator of wasting accompanying chronic invasive diseases (Beutler et al. 1985; Tracey et al. 1986). Acting in concert with other members of the cytokine network, TNF has now been clearly established as a central regulator of inflammation and immunity, mainly

Table 1. In vivo activities of TNF — context, rate and duration of TNF — synthesis

Homeostasis

Differentiation — tissue remodelling

Induction of cytokine cascades — synergy

Inflammation

Cellular immunity — infectious diseases

Cytotoxicity — tissue destruction

Vascular thrombosis and tumour necrosis

Cachexia and wasting toxicity

Shock and death

by modulating the functional state of cells that participate in such processes (reviewed by Beutler and Cerami 1989; Old 1990). For example, it has been shown that TNF augments the cytotoxicity of macrophages (Esparza et al. 1987), induces neutrophil adhesion and activation (Gamble et al. 1985) and regulates T and B cell growth and differentiation (Shalaby et al. 1988). The cell-specific effects of TNF are also exerted in a number of nonimmune cell types. The hemostatic properties of vascular endothelial cells are found to be modulated by TNF which induces the production of procoagulant activity (Nawroth and Stern 1986) and enhances the expression of adhesion molecules that bind neutrophils and monocytes (Gamble et al. 1985). Moreover, TNF is shown to be a growth factor for normal fibroblasts (Vilcek et al. 1986) and thymocytes (Ranges et al. 1988) and to interfere with the metabolism of adipocytes (Semb et al. 1987). In response to TNF many cell types are found to increase the production of several other factors, including IL-6, IL-1, colony stimulating factors, collagenase, PGE2, c fos, c-myc and histocompatibility antigens. Fine tuning of such circuits is very important to the defence of the host and to the restoration of homeostasis in the body following a microbial infection or a tissue injury.

Keywords

Transgenic Mouse Cerebral Malaria Chronic Arthritis Transgenic Mouse Line Tumour Necrosis Factor Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beutler B, Cerami A (1989) The biology of cachectin/TNF- a primary mediator of the host response. Ann Rev Immunol 7: 625–655CrossRefGoogle Scholar
  2. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977–980CrossRefGoogle Scholar
  3. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetcher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87: 3127–3131CrossRefGoogle Scholar
  4. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M (1988) Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-la. Clin Exp Immunol 73: 449–455Google Scholar
  5. Butler DM, Piccoli DS, Hart PH, Hamilton JA (1988) Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatology 15: 1463–1470Google Scholar
  6. Caput D, Beutler B, Hartog K, Thayer R, Shimer SB, Cerami A (1986) Identification of a common nucleotide sequence in the 3’-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83: 1670–1674CrossRefGoogle Scholar
  7. Carswell E, Old L, Cassel R, Green S, Fiore N, Williamson B (1975) An endotoxin serum factor that causes necrosis of tumours. Proc Natl Acad Sci USA 72: 36–66CrossRefGoogle Scholar
  8. Engelman H, Aderka D, Rubinstein M, Rotman D, Wallach D (1989) A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264: 11974–11980Google Scholar
  9. Esparza I, Mannel D, Ruppel A, Falk W, Krammer PH (1987) Interferongamma (IFN-y) and lymphotoxin (LT) or tumor necrosis factor ( TNF) synergize to activate macrophages for tumoricidal and schistosomulicidal functions. Lymphokine Res 6: 1715.Google Scholar
  10. Gamble JR, Harlan JM, Klebanoff SJ, Lopez AF, Vadas MA (1985) Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82: 8667–8671CrossRefGoogle Scholar
  11. Gitter BD, Labus JM, Lees SL, Scheetz ME (1989) Characteristics of human synovial fibroblast activation by IL-113 and TNFa. Immunology 66: 196–200Google Scholar
  12. Grau GE, Piguet PF, Vassali P, Lambert P-H (1989) Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data Immunol 112: 49–70Google Scholar
  13. Greaves DR, Wilson FD, Lang G, Kioussis D (1989) Human CD2 3’-flanking sequences confer high-level, T cell specific, position independent gene expression in transgenic mice. Cell 56: 979–986Google Scholar
  14. Hammer RE, Malka SD, Richardson JA, Tang JP, Taurog JD (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human 132m: an animal model of HLA-B27-associated human disorders. Cell 63: 1099–1112CrossRefGoogle Scholar
  15. Han J, Brown T, Beutler B (1990) Endotoxin-responsive sequences control cachectin/tumor necrosis factor at the translational level. J Exp Med 171: 465–475CrossRefGoogle Scholar
  16. Hang LM, Theofilopoulos AN, Dixon Ft (1982) A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J Exp Med 155: 1690–1701CrossRefGoogle Scholar
  17. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C (1990) Genes encoding tumor necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 7: 2239–2243CrossRefGoogle Scholar
  18. Husby G, Williams RC Jr (1988) Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1: 363–371CrossRefGoogle Scholar
  19. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, Sekiguchi T (1991) Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253: 1026–1028CrossRefGoogle Scholar
  20. Jasin HE (1988) Chronic arthritis in rabbits. Meth Enzymol 162: 379–385CrossRefGoogle Scholar
  21. Jue DM, Sherry B, Luedke C, Manogue KR, Cerami A (1990) Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin stimulated macrophages. Biochemistry 29: 8371–8377CrossRefGoogle Scholar
  22. Keffer, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 13: 4025–4031Google Scholar
  23. Kinkhabwala M, Sehajpal P, Skolnik E, Smith D, Sharma VK, Vlassara H, Cerami A, Suthanthiran M (1990) A novel addition to the T cell repertory; cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J Exp Med 171: 941–946CrossRefGoogle Scholar
  24. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL (1990) A second tumor necrosis factor receptor gene product can shed a naturally occuring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87: 8331–8335CrossRefGoogle Scholar
  25. Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53: 45–53Google Scholar
  26. Kruys V, Matinx O, Shaw G, Deschamps J, Huez G (1989) Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245: 852–855CrossRefGoogle Scholar
  27. Lewis M, Tartaglia TA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88: 2830–2834CrossRefGoogle Scholar
  28. Liu CC, Detmers PA, Jiang S, Young JD-E (1989) Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin. Proc Natl Acad Sci USA 86: 3286–3290CrossRefGoogle Scholar
  29. Luettig B, Decker T, Lohmann-Matthes ML (1989) Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J Immunol 143: 4034–4038Google Scholar
  30. Macnaul KL, Hutchinson NI, Parsons JN, Bayne EK, Tocci MJ (1990) Analysis of IL-1 and TNF-a gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J Immunol 145: 4154–4166Google Scholar
  31. Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–745CrossRefGoogle Scholar
  32. Old LJ (1990) Tumor necrosis factor. In: Bonavida B, Granger G (eds) Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy. Basel, Karger, pp 1–30Google Scholar
  33. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Celi 50: 555–563CrossRefGoogle Scholar
  34. Osborn L, Kunkel S, Nabel GJ (1989) Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc Natl Acad Sci USA 86: 2336–2340CrossRefGoogle Scholar
  35. Peck R, Brockhaus M, Frey JR (1989) Cell surface tumor necrosis factor ( TNF) acounts for monocyte-and lymphocyte-mediated killing of TNF-resistant target cells. Cell Immunol 122: 1–10Google Scholar
  36. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M (1990) A non-secretable cell surface mutant of tumour necrosis factor ( TNF) kills by cell to cell contact. Cell 63: 251–258Google Scholar
  37. Piguet PF, Grau GE, Allet B, Vassalli P (1987) Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 166: 1280–1289CrossRefGoogle Scholar
  38. Porteu F, Nathan C (1990) Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172: 599–607CrossRefGoogle Scholar
  39. Ranges GE, Zlotnik A, Espevik T, Dinarello CA, Cerami A, Palladino MAJr (1988) Tumor necrosis factor a/cachectin is a growth factor for thymocytes. J Exp Med 167: 1472–1478CrossRefGoogle Scholar
  40. Ridge SC, Oronsky AL, Kerwar SS (1988a) Type II collagen-induced arthritis in rats. Meth Enzymol 162: 355–360CrossRefGoogle Scholar
  41. Ridge SC, Zabriskie JB, Oronsky AL, Kerwar SS (1988b) Streptococcal cell wall-induced arthritis in rats. Meth Enzymol 162: 373–379CrossRefGoogle Scholar
  42. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detection of tumor necrosis factor a but not tumor necrosis factor [3 in rheumatoid arthritis synovial fluid and serum. Arthritis and Rheumatism 31: 1041–1045CrossRefGoogle Scholar
  43. Seckinger P, Isaaz S, Dayer JM (1989) Purification and biologic characterization of a specific tumor necrosis factor-a inhibitor. J Biol Chem 264: 11966–11973Google Scholar
  44. Semb H, Peterson J, Tavernier J, Olivecrona T (1987)Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 262: 8390–8394Google Scholar
  45. Shalaby MR, Espevic T, Rice GC, Ammann AJ, Figari IS, Ranges GE, Palladino MAJr (1988) The involvement of human tumor necrosis factors-a and -(3 in the mixed lymphocyte reaction. J Immunol 141: 499–503Google Scholar
  46. Shaw G, Kamen R (1986) A conserved AU sequence from the 3’-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659–667CrossRefGoogle Scholar
  47. Smith R, Baglioni C (1989) Multimeric structure of the tumor necrosis factor receptor of HeLa cells. J Biol Chem 264: 14646–14652Google Scholar
  48. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88: 9292–9296CrossRefGoogle Scholar
  49. Taurog JD, Argentiery DC, McReynolds RA (1988) Adjuvant arthritis. Meth Enzymol 162: 339–355CrossRefGoogle Scholar
  50. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark 1W, Hariri RJ, Fahey III TJ, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234: 470–474Google Scholar
  51. Trentham DE (1982) Collagen arthritis as a relevant model for rheumatoid arthritis. Arthr. Rheumatism 25: 911–915CrossRefGoogle Scholar
  52. Vilcek J, Palombella VJ, Henriksen-DeStefano D, Swenson C, Feinman R, Hirai M, Tsujimoto M (1986) Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163: 632–643CrossRefGoogle Scholar
  53. Wooley PH (1988) Collagen-induced arthritis in the mouse. Meth Enzymol 162: 361–373CrossRefGoogle Scholar
  54. Yocum DE, Esparza L, Dubry S, Benjamin JB, Volz R, Scuderi P (1989) Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cellular Immunol 122: 131–145CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • George A. Kollias

There are no affiliations available

Personalised recommendations